Skip to content

Randomized control trial of a single postoperative intravesical instillation of THP for prevention of intravesical recurrence after nephroureterectomy

Randomized control trial of a single postoperative intravesical instillation of THP for prevention of intravesical recurrence after nephroureterectomy - Randomized control trial of a single postoperative intravesical instillation of THP for prevention of intravesical recurrence after nephroureterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009682
Enrollment
90
Registered
2013-01-04
Start date
2012-08-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial carcinoma of upper urinary tract

Interventions

intravesical instillaiton of THP control

Sponsors

Department of Urology and Kidney Transplant Center, Hyogo Medical University Hospital
Lead Sponsor
Kobe city Medical Center General Hospital Kobe City Nishi-kobe Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Obtained informed consent 2)Pathologically confirmed urothelial carcinoma 3)No previous treatment of upper urinary tract tumors 4)No metastasis and resectable tumors 5)No previous bladder tumors and concomitant bladder tumors 6)ECOG PS 0-3 7)Have sufficient major organ functions

Exclusion criteria

Exclusion criteria: 1)Need adjuvant chemotherapy according to pathological result 2)Have active cancer except for upper urinary tract tumors 3)Inappropriate patients for this study judged by the physicians

Design outcomes

Primary

MeasureTime frame
Intravesical recurrence rate

Countries

Japan

Contacts

Public ContactToru Suzuki

Hyogo Medical University Hospital Department of Urology and Kidney Transplant Center

tosuzuki@hyo-med.ac.jp0798-45-6366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026